Literature DB >> 15956582

Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.

Woan-Eng Chan1, Hui-Hua Lin, Steve S-L Chen.   

Abstract

Palmitoylation of the cytoplasmic domain of the human immunodeficiency type virus type 1 (HIV-1) envelope (Env) transmembrane protein, gp41, has been implicated in Env targeting to detergent-resistant lipid rafts, Env incorporation into the virus, and viral infectivity. In contrast, we provide evidence here to show that HIV-1 infectivity, Env targeting to lipid rafts, and Env incorporation into the virus are independent of cytoplasmic tail palmitoylation. The T-cell (T)-tropic HXB2-based virus, which utilizes CXCR4 as the entry coreceptor, carrying a Cys-to-Ser mutation at residue 764 or 837 or at both replicated with wild-type (WT) virus replication kinetics in CD4+ T cells. The properties of Env expression, precursor processing, cell surface expression, and Env incorporation of these three mutant viruses were normal compared to those of the WT virus. These three mutant Env proteins all effectively mediated one-cycle virus infection. When the Cys residues were replaced by Ala residues, all single and double mutants still retained the phenotypes of infectivity, Env incorporation, and lipid raft localization of the WT Env. When Cys-to-Ala substitutions were introduced into the macrophage (M)-tropic ConB virus, which utilizes CCR5 as the coreceptor, these mutations did not affect the replication potential, Env phenotypes, lipid raft targeting, or Env assembly into the virus of the WT Env. These T- and M-tropic mutants also productively replicated in human primary CD4+ T cells. Moreover, mutations at both Cys residues significantly reduced the level of palmitoylation of the Env. Our results together support the notion that palmitoylation of the cytoplasmic tail of the HIV-1 Env is not essential for the HIV-1 virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956582      PMCID: PMC1143725          DOI: 10.1128/JVI.79.13.8374-8387.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.

Authors:  Y Kliger; Y Shai
Journal:  Biochemistry       Date:  1997-04-29       Impact factor: 3.162

2.  Membrane compartmentation is required for efficient T cell activation.

Authors:  R Xavier; T Brennan; Q Li; C McCormack; B Seed
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

Review 3.  Functional rafts in cell membranes.

Authors:  K Simons; E Ikonen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

4.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

Authors:  W K Wang; T Dudek; Y J Zhao; H G Brumblay; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.

Authors:  S S Chen; S F Lee; H J Hao; C K Chuang
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication.

Authors:  Woan-Eng Chan; Ya-Lin Wang; Hui-Hua Lin; Steve S-L Chen
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells.

Authors:  Karine Levesque; Yong-Sen Zhao; Eric A Cohen
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

9.  Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.

Authors:  Melissa Alexander; Yeou-cherng Bor; Kodimangalam S Ravichandran; Marie-Louise Hammarskjöld; David Rekosh
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity.

Authors:  Ilaria Schiavoni; Susanna Trapp; Anna Claudia Santarcangelo; Valentina Piacentini; Katherina Pugliese; Andreas Baur; Maurizio Federico
Journal:  J Biol Chem       Date:  2004-03-19       Impact factor: 5.157

View more
  26 in total

1.  Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infection.

Authors:  Steve S-L Chen; Polung Yang; Po-Yuan Ke; Hsiao-Fen Li; Woan-Eng Chan; Ding-Kwo Chang; Chin-Kai Chuang; Yu Tsai; Shu-Chen Huang
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

Review 2.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

3.  Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.

Authors:  Reem Berro; Per Johan Klasse; Danny Lascano; Ayanna Flegler; Kirsten A Nagashima; Rogier W Sanders; Thomas P Sakmar; Thomas J Hope; John P Moore
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.

Authors:  Eric Fleta-Soriano; Katarína Smutná; Javier P Martínez; Cristina Lorca Oró; S Kashif Sadiq; Gilles Mirambeau; Carmen Lopez-Iglesias; Marta Bosch; Albert Pol; Mark Brönstrup; Juana Diez; Andreas Meyerhans
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.

Authors:  Nicole Espy; Beatriz Pacheco; Joseph Sodroski
Journal:  Virology       Date:  2017-05-15       Impact factor: 3.616

Review 6.  Lipid rafts and pathogens: the art of deception and exploitation.

Authors:  Michael I Bukrinsky; Nigora Mukhamedova; Dmitri Sviridov
Journal:  J Lipid Res       Date:  2019-10-15       Impact factor: 5.922

7.  Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.

Authors:  Woan-Eng Chan; Chin-Kai Chuang; Shiou-Hwei Yeh; Mau-Sun Chang; Steve S-L Chen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 8.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 9.  Lipids and membrane microdomains in HIV-1 replication.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  Virus Res       Date:  2009-04-19       Impact factor: 3.303

10.  The Role of Lipids in Retrovirus Replication.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  Viruses       Date:  2010-05-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.